3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Genitourinary
1
Conditions
Prostatic Neoplasms
2
Neoplasms
2
Colorectal Neoplasms
2
Urinary Bladder Neoplasms
1
Pulmonary Disease, Chronic Obstructive
1
Motor Activity
1
Eye Diseases
1
Cognitive Dysfunction
1
Cardiovascular Diseases
1
Interventions
Colonoscopy
44
Standard of Care
29
Early Intervention, Educational
23
Methods
22
Blood Specimen Collection
21
Exercise
20
Educational Status
19
Interviews as Topic
13
Surveys and Questionnaires
12
Practice Guidelines as Topic
12
Patient Navigation
12
Counseling
12
Endoscopic Mucosal Resection
10
Drug Therapy
10
Oxaliplatin
9
Irinotecan
8
Fluorouracil
8
Surgical Procedures, Operative
7
Preoperative Exercise
7
Lidocaine
7
Bevacizumab
7
Therapeutics
6
Resistance Training
6
Occult Blood
6
Narrow Band Imaging
6
Mass Screening
6
Leucovorin
6
Diet
6
Decision Support Techniques
6
Control Groups
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase NA
×
Colorectal Neoplasms
×
Geritol
×
Clear all
NCT07341217
2026-01-14
CHEMOBRAIN
Lancaster University
Phase NA
Not yet recruiting
86 enrolled
NCT00270647
2018-02-28
PHS II
Brigham and Women's Hospital
Phase NA
Completed
14,641 enrolled